Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Jun 19;12(7):1054–1065. doi: 10.1111/jth.12591

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2014 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals, Inc. on behalf of International Society on Thrombosis and Haemostasis.

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Fig 1 — Representative thrombograms without and with rivaroxaban (3–1090 nmol L⁻¹), melagatran (3–948 nmol L⁻¹), or dabigatran (3–1090 nmol L⁻¹) in normal human platelet-poor plasma (A, C, E) and in protein C-deficient plasma (B, D, F) in the absence of recombinant human soluble thrombomodulin (rhs-TM).